These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7975158)
1. [Clinical use of MR tomography with a paramagnetic contrast medium Magnevist in patients with kidney cysts, tumors and hydronephrotic transformation]. Belichenko OI; Shariia MA; Orlov VA Vestn Rentgenol Radiol; 1994; (1):26-30. PubMed ID: 7975158 [TBL] [Abstract][Full Text] [Related]
2. [Magnetic resonance tomography in hydronephrotic transformation, cystic lesions and tumors of the kidneys in patients with arterial hypertension]. Shariia MA; Belichenko OI Ter Arkh; 1995; 67(4):21-6. PubMed ID: 7784967 [TBL] [Abstract][Full Text] [Related]
3. [Gd-DTPA in the diagnosis of brain metastasis]. Kornienko VN; Pronin IN Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209 [TBL] [Abstract][Full Text] [Related]
4. [Experience in clinical use of paramagnetic agent magnevist in the diagnosis of spine and spinal cord metastases]. Gunicheva NV; Akhadov TA; Grakova LS; Batukhtin EN Vestn Rentgenol Radiol; 1996; (6):15-8. PubMed ID: 9027071 [TBL] [Abstract][Full Text] [Related]
5. Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques. Semelka RC; Shoenut JP; Kroeker MA; MacMahon RG; Greenberg HM Radiology; 1992 Feb; 182(2):425-30. PubMed ID: 1732961 [TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance tomographic identification and characterization of renal space-occupying lesions using GE-sequences with application of Gd-DTPA]. Würstlin S; Arlart IP; Guhl L; Nagler-Reus N; Edelman RR Rofo; 1993 Jun; 158(6):518-24. PubMed ID: 8507841 [TBL] [Abstract][Full Text] [Related]
8. Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Eilenberg SS; Lee JK; Brown J; Mirowitz SA; Tartar VM Radiology; 1990 Aug; 176(2):333-8. PubMed ID: 2367649 [TBL] [Abstract][Full Text] [Related]
9. Normal and hydronephrotic kidney: evaluation of renal function with contrast-enhanced MR imaging. Kikinis R; von Schulthess GK; Jäger P; Dürr R; Bino M; Kuoni W; Kübler O Radiology; 1987 Dec; 165(3):837-42. PubMed ID: 3685363 [TBL] [Abstract][Full Text] [Related]
10. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Rofsky NM; Weinreb JC; Bosniak MA; Libes RB; Birnbaum BA Radiology; 1991 Jul; 180(1):85-9. PubMed ID: 2052729 [TBL] [Abstract][Full Text] [Related]
14. [Gadolinium-DTPA (Magnevist) as contrast medium for galactography]. Kaltenborn H; Schadmand S; Beck T; Thelen M Rofo; 1995 Nov; 163(5):457-9. PubMed ID: 8527765 [No Abstract] [Full Text] [Related]
15. Contrast-enhanced MR imaging of the kidneys and adrenal glands. Huch Böni RA; Debatin JF; Krestin GP Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):101-31. PubMed ID: 8673709 [TBL] [Abstract][Full Text] [Related]
16. [Gadolinium-DTPA in magnetic resonance tomography. Clinical use--indications]. Prayer L; Imhof H; Stiglbauer R; Kramer J; Wimberger D Rontgenblatter; 1989 Dec; 42(12):493-8. PubMed ID: 2609069 [TBL] [Abstract][Full Text] [Related]
17. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity]. Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501 [TBL] [Abstract][Full Text] [Related]
19. Renal lymphoma: demonstration by MR imaging. Semelka RC; Kelekis NL; Burdeny DA; Mitchell DG; Brown JJ; Siegelman ES AJR Am J Roentgenol; 1996 Apr; 166(4):823-7. PubMed ID: 8610558 [TBL] [Abstract][Full Text] [Related]
20. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance]. Torricelli P; Montanari N; De Santis M; Pollastri C Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]